The latest version of the everflex stent features the new entrust delivery system, which enables physicians to consistently place stents with accuracy, while providing the ease of a onehanded device. Medtronic, everflex selfexpanding peripheral stent with entrust delivery system, nitinol, 5, 0. The stent ends are slightly vaulted inwardly in order to minimize possible airway injury from the stent edges. Results of the protege everflex 200mmlong nitinol stent ev3 in. Listing a study does not mean it has been evaluated by the u. The everflex selfexpanding peripheral stent system is now indicated for use in the superficial femoral artery sfa andor proximal popliteal artery. Mdt has proven to provide sustained patency in the treatment of long, complex lesions in the superficial femoral sfa and popliteal arteries, according to the threeyear results of the durability ii study, which are reported in the recent issue of catheterization and cardiovascular. Boston scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Ruptured thoracoabdominal aneurysm treatment with modified. Flexible slink provides unparalleled flexibility, deliverability and vessel conformability allowing you to deal with the most complicated anatomies.
The overall stent geometry is designed to maintain a constant length over the entire range of possible diameters. Safety and efficacy of transhepatic and transsplenic. Biflex stents 3 offer a new main route that dif fers from the described wellknown balloon expandable and selfexpanding stent types, as summarised in t able 1. Medtronic launches the entrust delivery system in the united. Supera peripheral stent system abbott abbot vascular. Everflex selfexpanding peripheral stent system instructions for use device description the everflex selfexpanding peripheral stent system is a selfexpanding nitinol stent system intended for permanent implantation. One overall concern for stent technology is the risk of stent fracture because of movement, especially in the high usage area of the femoropopliteal artery. Jul 06, 2018 baremetal biliary stent a sterile nonbioabsorbable tubular device intended to be implanted in an obstructed biliary duct e. Covidien launches everflex plus stent system in europe. The selfexpanding stent is made of a nickel titanium alloy nitinol and comes premounted on a 6 f, 0. The everflex selfexpanding peripheral stent system has received fda approval for the treatment of atherosclerosis in the iliac arteries. The present study details our initial experience with the routine use of the novel protege everflex long selfexpanding nitinol stent for. In its fullhard condition, on the other hand, it exhibits enough.
First clinical experience with the innova versus the protege everflex selfexpanding bare metal stents in superficial femoral artery occlusions. The everflex selfexpanding peripheral stent system everflex stent is a self expanding nitinol stent system intended for permanent implantation. Indications, contraindications, warnings and instructions. Covidien launches everflex selfexpanding peripheral stent. Stent d is an ultrathane amplatz ureteral stent cook, bloomington.
Everflex selfexpanding peripheral stent with entrust. The delivery system consists mainly of an inner shaft and an outer sheath with radiopaque markers, and a tuohy. It has the capability of simulating the complete lifecycle of the stent and stent insertion equipment including manufacturing laser cutting, annealing, insertion or crimping, insertion bending, torsion, extension, expansiondeployment lumen shape and diameter and cycling. In ev3s rigorous simulated fatigue testing, the protege everflex survived significantly longer than any competitive stent tested. Peripheral and biliary stents vascular stenting medtronic. The stent delivery system and nitinol platform are the same as the innova selfexpanding stent boston scientific, marlborough, ma, usa, which is purpose built for use in the superficial femoral or proximal popliteal arteries. Mdt today announced the launch of its entrust delivery system in the united states. Ultra thin stent struts for ultra large lumen gain. In addition to the new indication, it is now available in a 200 mm length. Migration resistance the progressive step flared ends may assist in anchoring the stent within the esophageal lumen. Information about your procedure from the british association. The new entrust delivery system enables physicians to place medtronics everflex selfexpanding peripheral stent, while maintaining a low profile and providing the ease of a onehanded device.
Treat peripheral artery disease with the everflex selfexpanding biliary stent. April 1, 2015 dublin the everflex selfexpanding peripheral stent system from medtronic plc nyse. Baremetal biliary stent a sterile nonbioabsorbable tubular device intended to be implanted in an obstructed biliary duct e. First clinical experience with the innova versus the protege. In its fully annealed condition, stainless steel is easily deformable and, therefore, the standard material for balloonexpandable stents. Predilation may not be required, depending on stricture lumen diameter. The supera peripheral stent is indicated for the superficial femoral artery sfa and the proximal popliteal artery. Medtronic launches the entrust delivery system in the. Boston scientific corporation, innova vascular selfexpanding stent system, nitinol, 6, 0. Now with a much wider range in stent shapes, lengths, and diameters, clinicians can choose a stent configuration that precisely meets their biliary duct stenting requirements.
Safety and effectiveness study of everflex stent to treat symptomatic femoralpopliteal atherosclerosis durability ii the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. The quickplacev biliary stenting system delivers enhanced stent insertion and easier deployment along with an array of stents offering optimal flexibility and an improved design. The everflex selfexpanding stent system is a nitinol stent system that expands to a predetermined diameter to reopen narrowed stenotic. We are a liquidator of sutures and other surgical items from ethicon, covidien autosuture, synthes, stryker, arthrex and are able to pass our savings on to you.
As a result of this unique design the stent has virtually no foreshortening. Stents a and b are manufactured by and shown courtesy of cook urological, spencer, ind. The everflex selfexpanding peripheral stent system. The broad size matrix 20 mm 200 mm allows physicians to. Complications of ureteral stent placement radiographics. First clinical experience with the innova versus the. A survey of stent designs university of southampton. The chimney technique for celiac trunk, sma, and right renal artery periscope configuration was performed. The everflex stent is made of a nickel titanium alloy nitinol and is available in diameters 6, 7, and 8 mm and lengths 20, 30, 40, 60, 80, 100, 120, 150, and 200 mm. Clinical results following stent implantation in the superficial femoral artery sfa are limited due to restenosis, often caused by stent fractures. Sirolimus eluting polymerfree coronary stent system thanks to the proven polymerfree matrix coating, it provides continuous and controlled drug delivery. Treat lesions in either the sfa, proximal popliteal, or common andor external iliac arteries with confidence, knowing that the durability trial series demonstrated safety and efficacy of. Stent c is a flexima ureteral stent boston scientific. Fda approves peripheral stent system for iliac disease.
The device brand name is the cordis precise nitinol stent system. A total of 158 protege everflex stents were used to treat 100 lesions. Safety and efficacy of transhepatic and transsplenic access. Sirolimus eluting polymerfree coronary stent system. Everflex peripheral stent from medtronic delivers sustained. New ev3 prb3508040080 protege everflex selfexpanding.
British association of urological surgeons baus limited. This postapproval study is designed to confirm the longterm safety and effectiveness of the everflex selfexpanding stent system for the treatment of atherosclerotic superficial femoral artery sfa and proximal popliteal arteries. Initial clinical experience with the protege everflex long. The fully covered stent may be reconstrained up to 75% of deployment and 2 times during the initial stent placement procedure. The voyager pad trial showed patients with symptomatic peripheral artery disease pad who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg had a 15 percent reduction in the risk of major adverse limb and cardiovascular events. A survey of stent designs 9 additions of molybdenum and niobium. Drugeluting stents promise to reduce restenosis following endovascular treatment of diseased arteries, but. When it comes to stent place radial strength ment, micromarker technology. The eluvia vascular stent system is a selfexpanding stent made of a nickel titanium alloy nitinol. Oct 27, 2014 the everflex selfexpanding peripheral stent system has received fda approval for the treatment of atherosclerosis in the iliac arteries. An endovascular leak from the distal landing zone of the sma stent graft was treated using a. The everflex stent cell geometry, shown in figure 1, includes three 3 wave. The broad size matrix 20 mm 200 mm allows physicians to choose the most appropriate singlestent fit.
The new medical device is designed for the treatment of peripheral arterial disease and is designed to be the most durable addition to the everflex range, which made its debut in 2006. This product line is serviced by the following clinical divisions. New data from the durability iliac trial confirm the safety and effectiveness of primary stenting with two selfexpanding stent systems for the treatment of symptomatic iliac artery disease. The everflex selfexpanding peripheral stent with entrust delivery system is intended to improve luminal diameter in the treatment of symptomatic denovo or restenotic lesions up to 140 mm in length in the native superficial femoral artery sfa andor proximal popliteal arteries with reference vessel diameters ranging from 4. Everflex peripheral stent system related content the voyager pad trial showed patients with symptomatic peripheral artery disease pad who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg had a 15 percent reduction in the risk of major adverse limb and cardiovascular events when. Covidien, plymouth, mn with the same diameter or a 1.
In nonclinical testing, the zilver vascular stent produced maximum temperature rises of 0. The intention of this study was to treat all lesions with as few stents as possible. Covidien has announced the launch of its everflex selfexpanding peripheral stent with entrust delivery system in australia and new zealand. Sep 01, 2002 stent b is a 7f silicone stent with holes in the loops only. The everflex selfexpanding peripheral stent system everflex stent is a selfexpanding nitinol stent system intended for permanent implantation. This 10f stent has a hydrophilic coating and holes in the loops only. Treat peripheral artery disease with the everflex selfexpanding biliary stent with the entrust delivery system. The everflex selfexpanding stent system was evaluated in a study and proximal popliteal by using the everflex nitlnol stent system ii. Stent placement accuracy the coaxial delivery system is designed to result in 1. Quickplacev biliary stenting system olympus america.
Covidien has announced the launch of its nextgeneration everflex plus selfexpanding peripheral stent system in europe. Nitinol stent implantation in long superficial femoral artery lesions. The stent is cut from a nitinol tube in an open lattice design, and has. Intended for palliation of malignant neoplasms in the biliary tree. This is a multicenter, nonrandomized, single arm study to compare pta and primary stenting using a single protege everflex stent to performance goals of pta alone in the treatment of atherosclerotic superficial femoral artery sfa and proximal popliteal lesions. The rb4 file stores some kind of backup data used by trend antivirus. Between march 2008 and june 2009, 100 patients 66 men presenting with 100 symptomatic tasc c and d femoropopliteal lesions were treated with at least one 200mmlong protege everflex stent. Choose the everflex selfexpanding peripheral stent system for its combined benefits of durability and deployment accuracyall in a broad range of sizes. The everflex selfexpanding peripheral stent system is a selfexpanding nitinol stent system intended for permanent implantation. Covidien launches everflex selfexpanding peripheral stent in.
Try a universal file viewer in addition to the products listed above, i would suggest that you try a universal file viewer like free file viewer. Everflex selfexpanding peripheral stent system ordering. Stricture resolution the multiple wire braided construction is engineered to allow the wallflex esophageal stent to adjust to forces from the esophageal anatomy such as strictures and peristalsis. Between february and march 2006 a total of 15 everflex nitinol stents were implanted in 12 patients with either total sfa occlusions.
It may be a mesh structure or a continuous tube and is made entirely of metal e. The selfexpanding stent is made of a nickel titanium alloy nitinol and comes premounted on a 6f, 0. A single stent strategy in patients with lifestyle limiting. Find this technical manual in the product labeling supplied with each device or. A single stent strategy in patients with lifestyle. Nov 07, 2014 new data from the durability iliac trial confirm the safety and effectiveness of primary stenting with two selfexpanding stent systems for the treatment of symptomatic iliac artery disease. The protege everflex selfexpanding stent system employs the latest nitinol selfexpanding stent technology to provide previously undemonstrated durability. Everflex selfexpanding peripheral stent with entrust delivery system clinical study the safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Find this technical manual in the product labeling supplied with each device or by calling technical support for. Results of the protege everflex 200mmlong nitinol stent. April 2020 british association of urological surgeons baus limited questions you may wish to ask. Market entry durability i trial europe starts enrollment 5 mm stent and short. Safety and effectiveness study of everflex stent to treat.
37 1156 728 819 1471 1233 24 1147 721 1063 886 259 789 393 858 821 1503 561 1487 38 1227 909 860 29 720 185 903 31 1043 578 767 283 291 1323 230 1324 269 197